tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:MDNA Stock Latest News

Medicenna Partners with Fondazione Melanoma Onlus for Pioneering Melanoma Trial
Company AnnouncementsMedicenna Partners with Fondazione Melanoma Onlus for Pioneering Melanoma Trial
2d ago
Medicenna’s MDNA11 Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Medicenna’s MDNA11 Study: A Potential Game-Changer in Cancer Treatment?
12d ago
MDNA
Medicenna to Present Updated MDNA11 Data at ESMO Congress 2025
PremiumCompany Announcements
Medicenna to Present Updated MDNA11 Data at ESMO Congress 2025
16d ago
Medicenna Therapeutics Corp: Positioned for Growth in the PD-1 Bispecific Antibody Market
PremiumRatings
Medicenna Therapeutics Corp: Positioned for Growth in the PD-1 Bispecific Antibody Market
16d ago
Medicenna Therapeutics to Showcase Innovations at Upcoming Conferences
PremiumCompany Announcements
Medicenna Therapeutics to Showcase Innovations at Upcoming Conferences
19d ago
Medicenna Therapeutics initiated with a Buy at Lucid Capital
PremiumThe FlyMedicenna Therapeutics initiated with a Buy at Lucid Capital
25d ago
Promising Developments in Medicenna Therapeutics Corp’s ABILITY-1 Trial Justify Buy Rating
Premium
Ratings
Promising Developments in Medicenna Therapeutics Corp’s ABILITY-1 Trial Justify Buy Rating
1M ago
Medicenna to Engage Investors at ROTH Healthcare Conference
Premium
Company Announcements
Medicenna to Engage Investors at ROTH Healthcare Conference
1M ago
Medicenna Therapeutics Announces Shareholder Meeting Results and Leadership Updates
PremiumCompany Announcements
Medicenna Therapeutics Announces Shareholder Meeting Results and Leadership Updates
1M ago
Medicenna to Present at H.C. Wainwright Global Investment Conference
PremiumCompany Announcements
Medicenna to Present at H.C. Wainwright Global Investment Conference
2M ago
Medicenna Therapeutics Reports Strong Clinical Progress and Financial Stability in Q1 Fiscal 2026
PremiumCompany Announcements
Medicenna Therapeutics Reports Strong Clinical Progress and Financial Stability in Q1 Fiscal 2026
3M ago
Medicenna Expands IP Portfolio with Five New Patents for Superkines
PremiumCompany Announcements
Medicenna Expands IP Portfolio with Five New Patents for Superkines
3M ago
Medicenna Reports Promising Fiscal 2025 Results and Advances in Immunotherapy Programs
PremiumCompany AnnouncementsMedicenna Reports Promising Fiscal 2025 Results and Advances in Immunotherapy Programs
5M ago
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Medicenna Unveils Promising Preclinical Results for Novel Cancer Therapy
Premium
Company Announcements
Medicenna Unveils Promising Preclinical Results for Novel Cancer Therapy
6M ago
Promising Clinical Trial Results Boost Buy Rating for Medicenna Therapeutics Corp
PremiumRatings
Promising Clinical Trial Results Boost Buy Rating for Medicenna Therapeutics Corp
6M ago
Medicenna’s MDNA11 Shows Promising Results in Cancer Trial
PremiumCompany Announcements
Medicenna’s MDNA11 Shows Promising Results in Cancer Trial
6M ago
Medicenna to Present at 2025 Healthcare Investor Conference
PremiumCompany Announcements
Medicenna to Present at 2025 Healthcare Investor Conference
7M ago
Medicenna to Present at Healthcare Innovation Conference
PremiumCompany Announcements
Medicenna to Present at Healthcare Innovation Conference
7M ago
Medicenna to Present Key Updates at AACR 2025
PremiumCompany AnnouncementsMedicenna to Present Key Updates at AACR 2025
8M ago
Medicenna’s MDNA11 Shows Promising Results in Cancer Treatment
Premium
Company Announcements
Medicenna’s MDNA11 Shows Promising Results in Cancer Treatment
9M ago
Medicenna Reports Promising ABILITY-1 Trial Results and Strong Financial Position for 2025
Premium
Company Announcements
Medicenna Reports Promising ABILITY-1 Trial Results and Strong Financial Position for 2025
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >